These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2991712)

  • 21. Heat inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III.
    van Beers D; Duys M; Maes M; Biarent D; Haumont D
    J Virol Methods; 1985 Dec; 12(3-4):329. PubMed ID: 3009518
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for HTLV-III antibodies: the relation between prevalence and positive predictive value and its social consequences.
    JAMA; 1985 Jun; 253(23):3395-8. PubMed ID: 2987557
    [No Abstract]   [Full Text] [Related]  

  • 23. Heat inactivation of serum may interfere with HTLV-III/LAV serology.
    van den Akker R; Hekker AC; Osterhaus AD
    Lancet; 1985 Sep; 2(8456):672. PubMed ID: 2863663
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-HTLV-I antibody and anti-HIV antibody in hemophiliacs, patients with renal disease and blood donors].
    Kohno S; Masuyama Y; Dohtsu Y; Miyazaki T; Koga H; Yokoyama K; Taura K; Harada T; Yamaguchi K; Izumikawa K
    Kansenshogaku Zasshi; 1987 May; 61(5):567-73. PubMed ID: 2822821
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of HTLV III screening tests in Christchurch.
    Field D; Whyte G; Robertson S
    N Z Med J; 1985 Nov; 98(791):992-3. PubMed ID: 3001606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTLV-III antibody testing: the false-negative rate.
    Yomtovian R
    JAMA; 1986 Feb; 255(5):609. PubMed ID: 3003410
    [No Abstract]   [Full Text] [Related]  

  • 28. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III.
    Sayers MH; Beatty PG; Hansen JA
    Transfusion; 1986; 26(1):113-5. PubMed ID: 3003973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS: the significance of anti-HTLV-III antibodies.
    Robinson PA; Brough J; Haddy L; Belshe RB; Khakoo R; Stevenson MM
    W V Med J; 1985 Sep; 81(9):194-7. PubMed ID: 2998098
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
    Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
    J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HTLV-III testing of donor blood imminent; complex issues remain.
    Goldsmith MF
    JAMA; 1985 Jan; 253(2):173-5, 179-81. PubMed ID: 2981368
    [No Abstract]   [Full Text] [Related]  

  • 35. Status report on the acquired immunodeficiency syndrome. Human T-cell lymphotropic virus type III testing. Council on Scientific Affairs.
    JAMA; 1985 Sep; 254(10):1342-5. PubMed ID: 2991616
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation].
    Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins.
    Lange JM; van den Berg H; Dooren LJ; Vossen JM; Kuis W; Goudsmit J
    J Infect Dis; 1986 Jul; 154(1):171-4. PubMed ID: 3011923
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of a new assay for antibodies to LAV/HTLV III.
    Maskill W; Healey D; Wootten A; Silvester C; Johnson S; O'Dwyer C; Jacklin R; Pringle R; Gust I; Harden P
    J Virol Methods; 1986 Jul; 13(4):273-8. PubMed ID: 3018016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive anti-HTLV-III.
    Goldbaum J
    Med J Aust; 1985 Sep; 143(7):317. PubMed ID: 2995777
    [No Abstract]   [Full Text] [Related]  

  • 40. Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western blotting.
    Fang CT; Darr F; Kleinman S; Wehling RH; Dodd RY
    Transfusion; 1986; 26(2):208-9. PubMed ID: 3006302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.